newsfilter
← Interviews
Milken Institute48 min

A Conversation with FDA Commissioner Scott Gottlieb

Scott Gottlieb, Michael Milken, Indra Nooyi

Conference Presentation, Fireside Chat, Panel

This summit convened experts and FDA leadership to address critical public health challenges, including the link between sleep deprivation and obesity, the scaling of screen time interventions, and the opioid epidemic. Regulatory strategies were detailed for reducing opioid exposure through shorter prescription durations, while new tobacco policies aim to minimize nicotine addiction in combustible products and regulate youth-targeted vaping technologies. Additionally, the discussion covered FDA responses to supply chain disruptions in Puerto Rico following a hurricane and the development of regulatory frameworks for emerging digital health and artificial intelligence tools.